Michele Buemi

TL;DR: Plasma ADPN levels are an inverse predictor of cardiovascular outcomes among patients with end-stage renal disease and are related to several metabolic risk factors in a manner consistent with the hypothesis that this protein acts as a protective factor for the cardiovascular system.

TL;DR: In patients with CKD, NGAL closely reflects the entity of renal impairment and represents a strong and independent risk marker for progression of CKD.

TL;DR: NGAL levels predict the future appearance of acute kidney injury after treatments potentially detrimental to the kidney and even the acute worsening of unstable nephropathies, and recent evidence suggests that NGAL somehow may be involved in the pathophysiological process of chronic renal diseases.

TL;DR: In vivo recombinant human erythropoietin effects on brain ischemic injury could be due to inhibition of NO overproduction, as indicated by reduction in nitrite and nitrate in the hippocampus, as observed after ischemia.

TL;DR: A well-functioning vascular access (VA) is a mainstay to perform an efficient hemodialysis (HD) procedure and has the lowest association with morbidity and mortality, and for this reason AVF use is strongly recommended by guidelines from different countries.